Editorials
After years of neglect, I’m glad to see Congress give drug safety the attention it deserves. Last week, Reps. John D. Dingell (D-MI 15), Frank Pallone, Jr. (D-NJ 06) and Bart Stupak (D-MI 01) introduced the Food and Drug Administration Globalization Act of 2009 (H.R.759). In addition to addressing several food safety issues, the proposed legislation addresses the real threat of substandard and counterfeit drugs.
The RPSGB and the MHRA have collaborated on new guidance for pharmacists which explains the causes and consequences of counterfeiting and provides pharmacists with practical advice on detecting and reporting suspected counterfeit medicines. The guidance will be available at www.rpsgb.org and at www.mhra.gov.uk from 26 May 2006. The guidance has been jointly developed by the Royal Pharmaceutical Society of Great Britain (RPSGB) and the Medicines and Healthcare products Regulatory Agency (MHRA) following a meeting of the Society’s Practice Committee where the dangers of counterfeit medicines were debated. 24 May 2006 Read the full story at www.mhra.gov.uk.
- « Previous
- 1
- 2
- 3
- 4